Skip to content
Surf Wiki
Save to docs
arts

From Surf Wiki (app.surf) — the open knowledge base

TiHKAL

1997 book by Alexander Shulgin and Ann Shulgin


1997 book by Alexander Shulgin and Ann Shulgin

FieldValue
nameTiHKAL: The Continuation
imageTihkal.jpg
image_size200px
captionCover of *TiHKAL*, 1st ed.
authorAlexander and Ann Shulgin
countryUnited States
subjectPharmacology, Autobiography, Psychedelic drugs
publisherTransform Press
release_date1997
media_typePaperback
pages*xxviii*, 804 p.
isbn0-9630096-9-9
oclc38503252
preceded_byPiHKAL (1991)

TiHKAL: The Continuation, also known as Tryptamines I Have Known and Loved, is a 1997 book written by Alexander Shulgin and Ann Shulgin. It is about a family of psychoactive drugs known as tryptamines, which includes psychedelics, other hallucinogens, and entactogens. The book has two halves, and the second part of the book contains detailed entries on 55tryptamines. TiHKAL is a sequel to PiHKAL: A Chemical Love Story (Phenethylamines I Have Known and Loved) (1991).

Content

TiHKAL, much like its predecessor PiHKAL, is divided into two parts. The first part, for which all rights are reserved, begins with a fictionalized autobiography, picking up where the similar section of PiHKAL left off; it then continues with a collection of essays on topics ranging from psychotherapy and the Jungian mind to the prevalence of DMT in nature, ayahuasca and the war on drugs.

The second part of TiHKAL, which may be conditionally distributed for non-commercial reproduction , is a detailed synthesis manual for 55tryptamines (many discovered by Alexander Shulgin himself), including their chemical structures, doses, durations, and commentary. It includes entries on compounds including simple tryptamines like dimethyltryptamine (DMT), psilocin, and 5-MeO-DMT, α-alkyltryptamines like α-methyltryptamine (AMT), β-carbolines or harmala alkaloids like harmaline, the iboga alkaloid ibogaine, and lysergamides like LSD. Whereas PiHKAL had 179entries on phenethylamines, TiHKAL has only 55entries. Shulgin has made the second part freely available on Erowid while the first part is available only in the printed text.

Members of Shulgin's research who contributed to the experience reports included Shulgin himself, Ann Shulgin, Myron Stolaroff, and Jean Stolaroff, among others.

Response

As with PiHKAL, the Shulgins were motivated to release the synthesis information as a way to protect the public's access to information about psychedelic compounds, a goal Alexander Shulgin has noted many times. Following a raid of his laboratory in 1994 by the United States DEA, Richard Meyer, spokesman for DEA's San Francisco Field Division, stated that "It is our opinion that those books referring to the previous work, PiHKAL are pretty much cookbooks on how to make ‘controlled drugs’. Agents tell me that in clandestine labs that they have raided, they have found copies of those books."

Notable compounds

Some compounds in TiHKAL, including [dimethyltryptamine (DMT), psilocybin (4-PO-DMT), psilocin (4-HO-DMT), bufotenin (5-HO-DMT), 5-MeO-DMT, α-methyltryptamine (AMT), lysergic acid diethylamide (LSD), harmaline, and ibogaine, are widely known and/or used hallucinogens.

Tryptamines listed

#SubstanceChemical nameGroupDoseaDurationLink
1AL-LAD (6-allyl-6-nor-LSD)6-Allyl-*N*,*N*-diethyl-NLLysergamide80–160 μg6–8 hours[https://www.erowid.org/library/books_online/tihkal/tihkal01.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal01.shtml)
2DBT (dibutyltryptamine)*N*,*N*-Dibutyl-TTryptamineUnknownUnknown[https://www.erowid.org/library/books_online/tihkal/tihkal02.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal02.shtml)
3DET (diethyltryptamine)*N*,*N*-Diethyl-TTryptamine50–100 mg2–4 hours[https://www.erowid.org/library/books_online/tihkal/tihkal03.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal03.shtml)
4DiPT (diisopropyltryptamine)*N*,*N*-Diisopropyl-TTryptamine25–100 mg6–8 hours[https://www.erowid.org/library/books_online/tihkal/tihkal04.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal04.shtml)
5[α,*O*-DMS](5-meo-amt) (5-MeO-AMT)5-Methoxy-α-methyl-Tα-Alkyltryptamine2.5–4.5 mg12–18 hours[https://www.erowid.org/library/books_online/tihkal/tihkal05.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal05.shtml)
6DMT (dimethyltryptamine)*N*,*N*-Dimethyl-TTryptamineVariousbUp to 1 hour[https://www.erowid.org/library/books_online/tihkal/tihkal06.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal06.shtml)
7[2,α-DMT](2-a-dmt) (2-methyl-AMT)2,α-Dimethyl-Tα-Alkyltryptamine300–500 mg7–10 hours[https://www.erowid.org/library/books_online/tihkal/tihkal07.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal07.shtml)
8α,*N*-DMT (*N*-methyl-AMT)α,*N*-Dimethyl-Tα-Alkyltryptamine50–100 mg6–8 hours[https://www.erowid.org/library/books_online/tihkal/tihkal08.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal08.shtml)
9DPT (dipropyltryptamine)*N*,*N*-Dipropyl-TTryptamine100–250 mg2–4 hours[https://www.erowid.org/library/books_online/tihkal/tihkal09.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal09.shtml)
10EiPT (ethylisopropyltryptamine)*N*-Ethyl-*N*-isopropyl-TTryptamine24–40 mg4–6 hours[https://www.erowid.org/library/books_online/tihkal/tihkal10.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal10.shtml)
11α-ET (AET; α-ethyltryptamine)α-Ethyl-Tα-Alkyltryptamine100–150 mg6–8 hours[https://www.erowid.org/library/books_online/tihkal/tihkal11.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal11.shtml)
12ETH-LAD (6-ethyl-6-nor-LSD)6,*N*,*N*-Triethyl-NLLysergamide40–150 μg8–12 hours[https://www.erowid.org/library/books_online/tihkal/tihkal12.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal12.shtml)
13Harmaline (dihydroharmine)3,4-Dihydro-7-methoxy-1-methyl-BCβ-Carboline150–300 mg5–8 hours[https://www.erowid.org/library/books_online/tihkal/tihkal13.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal13.shtml)
14Harmine7-Methoxy-1-methyl-BCβ-Carboline300 mgUnknown[https://www.erowid.org/library/books_online/tihkal/tihkal14.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal14.shtml)
15[4-HO-DBT](4-ho-dbt)*N*,*N*-Dibutyl-4-hydroxy-T4-Hydroxytryptamine20 mgUnknown[https://www.erowid.org/library/books_online/tihkal/tihkal15.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal15.shtml)
16[4-HO-DET](4-ho-det)*N*,*N*-Diethyl-4-hydroxy-T4-Hydroxytryptamine10–25 mg4–6 hours[https://www.erowid.org/library/books_online/tihkal/tihkal16.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal16.shtml)
17[4-HO-DiPT](4-ho-dipt)*N*,*N*-Diisopropyl-4-hydroxy-T4-Hydroxytryptamine15–20 mg2–3 hours[https://www.erowid.org/library/books_online/tihkal/tihkal17.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal17.shtml)
184-HO-DMT (psilocin)*N*,*N*-Dimethyl-4-hydroxy-T4-Hydroxytryptamine10–20 mg3–6 hours[https://www.erowid.org/library/books_online/tihkal/tihkal18.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal18.shtml)
195-HO-DMT (bufotenin)*N*,*N*-Dimethyl-5-hydroxy-T5-Hydroxytryptamine8–16 mg i.v.1–2 hours[https://www.erowid.org/library/books_online/tihkal/tihkal19.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal19.shtml)
20[4-HO-DPT](4-ho-dpt)*N*,*N*-Dipropyl-4-hydroxy-T4-HydroxytryptamineUnknownUnknown[https://www.erowid.org/library/books_online/tihkal/tihkal20.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal20.shtml)
21[4-HO-MET](4-ho-met)*N*-Ethyl-4-hydroxy-*N*-methyl-T4-Hydroxytryptamine10–20 mg4–6 hours[https://www.erowid.org/library/books_online/tihkal/tihkal21.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal21.shtml)
22[4-HO-MiPT](4-ho-mipt)4-Hydroxy-*N*-isopropyl-*N*-methyl-T4-Hydroxytryptamine12–25 mg4–6 hours[https://www.erowid.org/library/books_online/tihkal/tihkal22.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal22.shtml)
23[4-HO-MPT](4-ho-mpt)4-Hydroxy-*N*-methyl-*N*-propyl-T4-HydroxytryptamineUnknownUnknown[https://www.erowid.org/library/books_online/tihkal/tihkal23.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal23.shtml)
24[4-HO-pyr-T](4-ho-pyr-t)4-Hydroxy-*N*,*N*-tetramethylene-TPyrrolidinylethylindole20 mgUnknown[https://www.erowid.org/library/books_online/tihkal/tihkal24.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal24.shtml)
25IbogaineA complexly substituted-TAzepinoindoleVariousc"Quite long"[https://www.erowid.org/library/books_online/tihkal/tihkal25.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal25.shtml)
26LSD (METH-LAD)*N*,*N*-Diethyl-LLysergamide60–200 μg8–12 hours[https://www.erowid.org/library/books_online/tihkal/tihkal26.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal26.shtml)
27MBT (methylbutyltryptamine)*N*-Butyl-*N*-methyl-TTryptamine250–400 mg4–6 hours[https://www.erowid.org/library/books_online/tihkal/tihkal27.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal27.shtml)
28[4,5-MDO-DiPT](4-5-mdo-dipt)*N*,*N*-Diisopropyl-4,5-methylenedioxy-TOther25 mgUnknown[https://www.erowid.org/library/books_online/tihkal/tihkal28.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal28.shtml)
29[5,6-MDO-DiPT](5-6-mdo-dipt)*N*,*N*-Diisopropyl-5,6-methylenedioxy-TOtherUnknownUnknown[https://www.erowid.org/library/books_online/tihkal/tihkal29.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal29.shtml)
30[4,5-MDO-DMT](4-5-mdo-dmt)*N*,*N*-Dimethyl-4,5-methylenedioxy-TOtherUnknownUnknown[https://www.erowid.org/library/books_online/tihkal/tihkal30.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal30.shtml)
31[5,6-MDO-DMT](5-6-mdo-dmt)*N*,*N*-Dimethyl-5,6-methylenedioxy-TOther5 mgUnknown[https://www.erowid.org/library/books_online/tihkal/tihkal31.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal31.shtml)
32[5,6-MDO-MiPT](5-6-mdo-mipt)*N*-Isopropyl-*N*-methyl-5,6-methylenedioxy-TOther50 mgUnknown[https://www.erowid.org/library/books_online/tihkal/tihkal32.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal32.shtml)
33[2-Me-DET](2-me-det) (2-methyl-DET)*N*,*N*-Diethyl-2-methyl-TOther80–120 mg6–8 hours[https://www.erowid.org/library/books_online/tihkal/tihkal33.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal33.shtml)
34[2-Me-DMT](2-n-n-tmt) (2-methyl-DMT)2,*N*,*N*-Trimethyl-TOther50–100 mg4–6 hours[https://www.erowid.org/library/books_online/tihkal/tihkal34.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal34.shtml)
35Melatonin (5-MeO-NAcT)*N*-Acetyl-5-methoxy-T*N*-Acetyltryptamine1–10 mg"A few hours"[https://www.erowid.org/library/books_online/tihkal/tihkal35.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal35.shtml)
36[5-MeO-DET](5-meo-det)*N*,*N*-Diethyl-5-methoxy-T5-Methoxytryptamine1–3 mg3–4 hours[https://www.erowid.org/library/books_online/tihkal/tihkal36.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal36.shtml)
37[5-MeO-DiPT](5-meo-dipt)*N*,*N*-Diisopropyl-5-methoxy-T5-Methoxytryptamine6–12 mg4–8 hours[https://www.erowid.org/library/books_online/tihkal/tihkal37.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal37.shtml)
38[5-MeO-DMT](5-meo-dmt)5-Methoxy-*N*,*N*-dimethyl-T5-MethoxytryptamineVariousd1–2 hours[https://www.erowid.org/library/books_online/tihkal/tihkal38.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal38.shtml)
39[4-MeO-MiPT](4-meo-mipt)*N*-Isopropyl-4-methoxy-*N*-methyl-TOther20–30 mg4–6 hours[https://www.erowid.org/library/books_online/tihkal/tihkal39.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal39.shtml)
40[5-MeO-MiPT](5-meo-mipt)*N*-Isopropyl-5-methoxy-*N*-methyl-T5-Methoxytryptamine4–6 mge4–6 hours[https://www.erowid.org/library/books_online/tihkal/tihkal40.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal40.shtml)
41[5,6-MeO-MiPT](5-6-meo-mipt)5,6-Dimethoxy-*N*-isopropyl-*N*-methyl-TOther75 mgUnknown[https://www.erowid.org/library/books_online/tihkal/tihkal41.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal41.shtml)
42[5-MeO-NMT](5-meo-nmt)5-Methoxy-*N*-methyl-T5-MethoxytryptamineUnknownUnknown[https://www.erowid.org/library/books_online/tihkal/tihkal42.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal42.shtml)
43[5-MeO-pyr-T](5-meo-pyr-t)5-Methoxy-*N*,*N*-tetramethylene-TPyrrolidinylethylindole0.5–2 mg"Several hours"[https://www.erowid.org/library/books_online/tihkal/tihkal43.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal43.shtml)
44[6-MeO-THH](6-meo-thh)6-Methoxy-1-methyl-1,2,3,4-tetrahydro-BCβ-CarbolineUnknownUnknown[https://www.erowid.org/library/books_online/tihkal/tihkal44.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal44.shtml)
45[5-MeO-TMT](5-meo-tmt)5-Methoxy-2,*N*,*N*-trimethyl-TOther75–150 mg5–10 hours[https://www.erowid.org/library/books_online/tihkal/tihkal45.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal45.shtml)
46[5-MeS-DMT](5-mes-dmt)*N*,*N*-Dimethyl-5-methylthio-TOther15–30 mg sm.[https://www.erowid.org/library/books_online/tihkal/tihkal46.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal46.shtml)
47MiPT (methylisopropyltryptamine)*N*-Isopropyl-*N*-methyl-TTryptamine10–25 mg3–4 hours[https://www.erowid.org/library/books_online/tihkal/tihkal47.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal47.shtml)
48α-MT (AMT; α-methyltryptamine)α-Methyl-Tα-Alkyltryptamine15–30 mgf12–16 hours[https://www.erowid.org/library/books_online/tihkal/tihkal48.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal48.shtml)
49NET (*N*-ethyltryptamine)*N*-Ethyl-TTryptamineUnknownUnknown[https://www.erowid.org/library/books_online/tihkal/tihkal49.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal49.shtml)
50NMT (*N*-methyltryptamine)*N*-Methyl-TTryptamineUnknownUnknown[https://www.erowid.org/library/books_online/tihkal/tihkal50.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal50.shtml)
51PRO-LAD (6-propyl-6-nor-LSD)6-Propyl-NLLysergamide100–200 μg6–8 hours[https://www.erowid.org/library/books_online/tihkal/tihkal51.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal51.shtml)
52pyr-T (pyrrolidinyltryptamine)*N*,*N*-Tetramethylene-TPyrrolidinylethylindoleUnknownUnknown[https://www.erowid.org/library/books_online/tihkal/tihkal52.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal52.shtml)
53T (tryptamine)TryptamineTryptamine250 mg i.v."Very short"[https://www.erowid.org/library/books_online/tihkal/tihkal53.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal53.shtml)
54Tetrahydroharmine (THH)7-Methoxy-1-methyl-1,2,3,4-tetrahydro-BCβ-Carboline300 mgUnknown[https://www.erowid.org/library/books_online/tihkal/tihkal54.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal54.shtml)
55α,*N*,*O*-TMS (5-MeO-α,*N*-DMT)α,*N*-Dimethyl-5-methoxy-Tα-Alkyltryptamine10–20 mg6–8 hours[https://www.erowid.org/library/books_online/tihkal/tihkal55.shtml](https://www.erowid.org/library/books_online/tihkal/tihkal55.shtml)
56[5-MeO-DALT](5-meo-dalt)g5-Methoxy-*N*,*N*-diallyl-T5-Methoxytryptamine12–20 mg2–4 hours[https://www.erowid.org/chemicals/5meo_dalt/5meo_dalt_info1.shtml](https://www.erowid.org/chemicals/5meo_dalt/5meo_dalt_info1.shtml) [https://isomerdesign.com/pihkal/read/tk/56](https://isomerdesign.com/pihkal/read/tk/56)
57DALT (diallyltryptamine)g*N*,*N*-Diallyl-TTryptamine40 mgUnknown[https://isomerdesign.com/pihkal/read/tk/57](https://isomerdesign.com/pihkal/read/tk/57)
**Acronyms** (in chemical names)**:** T = tryptamine; BC = β-carboline; L = lysergamide; NL = [6-norlysergamide](6-norlysergamide). **Footnotes:** a = Dose and duration for compounds are orally unless otherwise specified. b = DMT doses are 350mg orally, 60–100mg intramuscularly, subcutaneously, or smoked, and 4–30mg intravenously. c = Ibogaine dose is "from hundreds of [mg] up to [1g] or more". d = [5-MeO-DMT](5-meo-dmt) doses are 6–20mg smoked and 2–3 mg intravenously. e = [5-MeO-MiPT](5-meo-mipt) doses are 4–6mg orally and 12–20mg smoked. f = AMT doses are 15–30 mg orally and 5–20 mg smoked. g = The [5-MeO-DALT](5-meo-dalt) (#56) and DALT (#57) entries were not included in the published version of *TiHKAL* and were subsequently released in 2004.

In addition to TiHKAL, Shulgin has also described the properties of psychedelic tryptamines in humans in literature reviews.

References

References

  1. Ben Sessa. (2015). "The Psychedelic Policy Quagmire: Health, Law, Freedom, and Society". Bloomsbury Publishing.
  2. (1997). "TiHKAL: The Continuation". [[Transform Press]].
  3. {{CitePiHKAL
  4. (2021). "Better Living Through Chemistry". Better Living Through Film, Incorporated.
  5. (2018). "Self-Experiments with Psychoactive Substances: A Historical Perspective". Handb Exp Pharmacol.
  6. Bennett, Drake. (2005-01-30). "Dr. Ecstasy". New York Times Magazine.
  7. (2004-01-08). "DEA Raid of Shulgin's Laboratory". Erowid.
  8. (2010-05-02). "The Last Interview With Alexander Shulgin".
  9. (1994). "Hallucinogens: An Update". National Institute on Drug Abuse.
  10. (2003). "Hallucinogens: A Forensic Drug Handbook". Elsevier Science.
  11. Shulgin, Alexander T.. (1978). "Stimulants". Springer US.
  12. (1980). "Burger's Medicinal Chemistry". Wiley.
  13. (1982). "Psychotropic Agents, Part III: Alcohol and Psychotomimetics, Psychotropic Effects of Central Acting Drugs". Springer Berlin Heidelberg.
Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

Want to explore this topic further?

Ask Mako anything about TiHKAL — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report